Evidence map›Paper›PMID 38315202›Full record

ArticleActa diabetologica2024

Association of pro-inflammatory cytokines, adipokines and hepatokine with incident diabetes in India: a nested case-control study within CARRS cohort.

Ruby Gupta, Roopa Shivashankar, Dimple Kondal, Kuppan Gokulakrishnan, Shivani A Patel, Mohammed K Ali, K M Venkat Narayan, Viswanathan Mohan, Nikhil Tandon, Dorairaj Prabhakaran

Open access · greenAbstract read
In one paragraph

Article in Acta diabetologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Ruby GuptaCentre for Chronic Disease Control, New Delhi, India. ruby@ccdcindia.org.ORCID http://orcid.org/0000-0002-8487-6004
Roopa ShivashankarIndian Council for Medical Research, New Delhi, India.ORCID http://orcid.org/0000-0002-4361-9423
Dimple KondalCentre for Chronic Disease Control, New Delhi, India.ORCID http://orcid.org/0000-0002-1417-9510
Kuppan GokulakrishnanNational Institute of Mental Health and NeuroSciences, Bangalore, India.ORCID http://orcid.org/0000-0003-3167-8239
Shivani A PatelRollins School of Public Health, Emory University, Atlanta, USA.ORCID http://orcid.org/0000-0003-0082-5857
Mohammed K AliEmory Global Diabetes Research Center, Emory University, Atlanta, USA.ORCID http://orcid.org/0000-0001-7266-2503
K M Venkat NarayanEmory Global Diabetes Research Center, Woodruff Health Sciences Center, Emory University, Atlanta, USA.ORCID http://orcid.org/0000-0001-8621-5405
Viswanathan MohanMadras Diabetes Research Foundation, Chennai, India.ORCID http://orcid.org/0000-0001-5038-6210
Nikhil TandonAll India Institute of Medical Sciences, New Delhi, India.ORCID http://orcid.org/0000-0003-4604-1986
Dorairaj PrabhakaranCenter for Chronic Disease Control, New Delhi, India.ORCID http://orcid.org/0000-0002-3172-834X
Centre for Chronic Disease Control · INEmory University · USAll India Institute of Medical Sciences · INIndian Council of Medical Research · INMadras Diabetes Research Foundation · INNational Institute of Mental Health and Neurosciences · IN

Funding

Spousal Influences on Subclinical and Clinical Vascular and Myocardial DiseaseP01HL154996 · NHLBI · EMORY UNIVERSITY · PI Kabayam M Venkat Narayan · 2022 to 2026
$13.4M
NHLBI NIH HHS HHSN268200900026CNHLBI NIH HHS P01 HL154996Wellcome Trust
6 · The paper itself

Abstract

aimsTo study the association of pro-inflammatory markers with incident diabetes in India.

methodsWe did a nested case-control study within the CARRS (Centre for Ardiometabolic Risk Reduction in South Asia) cohort. Of the 5739 diabetes-free individuals at the baseline, 216 participants with incident diabetes and 432 age-, gender- and city-matched controls at 2-year follow-up were included. We measured high sensitive C-reactive protein (hsCRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 ( MCP-1), adiponectin, leptin and fetuin-A in the stored baseline blood samples. We did multivariate conditional logistic regression to estimate association of inflammatory markers (as quartiles) and incident diabetes. Covariates were baseline fasting plasma glucose (FPG) and lipids, body mass index (BMI), family history of diabetes, smoking and alcohol use.

resultsBaseline hsCRP and TNF-α were higher, and IL-6 and adiponectin were lower among cases vs. controls. In multivariate conditional logistic regression models, only quartile-3 (odds ratio [OR]: 2.96 [95% CI:1.39, 6.30]) and quartile-4 (OR: 2.58 [95% CI: 1.15, 5.79]) of TNF-α and quartile-4 of MCP-1 (OR: 2.55 [95% CI: 1.06, 6.16]) were positively associated with diabetes after adjusting for baseline FPG and BMI. These associations did not remain after adjusting for family history. High level (quartile-4) of IL-6 was negatively associated with diabetes after adjusting for all factors (OR: 0.18 [95% CI: 0.06, 0.55]).

conclusionsHigher TNF-α and MCP-1 levels and lower IL-6 were associated with higher risk of developing diabetes. Better understanding and potential methods of addressing these biomarkers, especially in relation to family history, are needed to address diabetes in South Asians.

Indexed as

AdipokinesAdultBiomarkersCase-Control StudiesChemokine CCL2Cohort StudiesC-Reactive ProteinCytokinesDiabetes Mellitus, Type 2FemaleHumansIncidenceIndiaInterleukin-6MaleMiddle AgedAdipokinesBiomarkersCCL2 protein, humanChemokine CCL2C-Reactive ProteinCytokinesInterleukin-6Tumor Necrosis Factor-alphaAdipokinesCytokinesHepatokineshsCRPInflammationLipidsT2DM

Identifiers

PMID38315202
PMCPMC11812286
OpenAlexW4391533521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.